National Foundation for Cancer Research (NFCR) shared a post on LinkedIn:
“Glioblastoma Awareness Day — a day to shed light on one of the most aggressive and deadly forms of brain cancer.
We’re honoring the legacy of Steve Mathews, who defied the odds after a GBM diagnosis and became a source of strength and hope for countless families.
Steve was given just two years to live… but lived 27 more—thanks to a clinical trial and an unshakable will to keep going.
On this day of awareness, let’s remember why research matters and why every moment gained is a victory.
You can also read:
Glioblastoma Awareness Day 2025: Uniting for Progress and Hope
